Biotech

All Articles

Lilly- backed weight loss biotech files IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to...

Aelis' cannabis use drug fails phase 2b, steering Indivior to re-think $100M option

.Aelis Farma's hopes of getting a quick, beneficial choice on a $one hundred thousand possibility se...

ProKidney standstills phase 3 trial not needed for tissue treatment authorization

.ProKidney has actually stopped among a pair of stage 3 tests for its cell therapy for renal health ...

Vaxcyte climbs on 'spectacular' 31-valent PCV win versus Pfizer

.Vaxcyte unveiled what analysts referred to as "magnificent" phase 1/2 information for its 31-valent...

Recursion's human brain condition test reveals scant documentation of efficiency

.Recursion has actually discovered with an early examination of its own tech-enabled strategy to med...

Acepodia, Pfizer click on together for chemistry-based tissue treatment

.Call it a scenario of good chemistry: Acepodia, a biotech based on Nobel Prize-winning science, is ...

Praxis epilepsy drug lowers seizures in stage 2 hearing

.Praxis Accuracy Medicines has actually racked up an additional midphase gain in epilepsy this year,...

Three execs surrender as Dyne messages blended records for DMD applicant

.After running away a scientific grip a number of years back, Dyne Rehab has disclosed new period 1/...

Arrowhead fires off phase 3 records in rare metabolic disease ahead of market clash with Ionis

.Arrowhead Pharmaceuticals has revealed its own give in front of a prospective showdown with Ionis, ...

Pfizer, Valneva reveal lyme ailment chance effective for second enhancer

.Pfizer as well as Valneva might have regarding 2 additional years to hang around prior to they help...